{"nct_id":"NCT06881784","title":"Study of Daraxonrasib (RMC-6236) in Previously Treated Patients With RAS Mutated NSCLC (RASolve 301)","status":"RECRUITING","status_verified_date":"2025-10","start_date":"2025-05-06","start_date_type":"ACTUAL","primary_completion_date":"2027-12-01","primary_completion_date_type":"ESTIMATED","completion_date":"2030-12-01","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["RVMD"]}